ALL ABOUT DAPAGLIFLOZIN DR JOHN MCMURRAY PI DAPAHF DARREN MCGUIRE PI DECLARE TIMI DR VIJAY V DR J S

Metabolodiuretic Promise of Dapagliflozin: The Sweet Spot in Heart Failure".

The spectrum of Dapagliflozin treatment will expand with the presence of two international speakers:

1) Prof. (Dr.) John McMurray: Principal Investigator- DAPA-HF & many other renowned trials

2) Dr. Darren McGuire: Principal Investigator- DECLARE-TIMI 58 & many other renowned trials

Along with international faculties, two eminent speakers from India will also join to add Indian perspective on the role of Dapagliflozin in the management of patients in India:

1) Dr. Vijay Viswanathan (MD, Ph.D., FRCP (London & Glasgow)), Chennai
2) Dr. J S Hiremath: (DM (Cardio), DNB (Cardio), FACC), Pune